<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Cardiovascular problems in the post-anesthesia care unit (PACU)
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Cardiovascular problems in the post-anesthesia care unit (PACU)
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Cardiovascular problems in the post-anesthesia care unit (PACU)
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David Broussard, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kelly Ural, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Natalie F Holt, MD, MPH
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jonathan B Mark, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Nancy A Nussmeier, MD, FAHA
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jun 08, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1455212825">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hemodynamic aberrations in the post-anesthesia care unit (PACU) include hypotension, hypertension, and/or cardiac arrhythmias, and may be caused by or result in cardiovascular complications (eg, myocardial ischemia, decompensated heart failure). Although nausea and vomiting or respiratory problems occur more frequently, cardiovascular events are the third most common problem requiring treatment in the immediate postoperative period [
         <a href="#rid1">
          1-3
         </a>
         ]. In this topic, we review the diagnosis and treatment of causes of hemodynamic instability and cardiovascular complications in the immediate postoperative period. Complications that occur after cardiac surgery are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1627.html" rel="external">
          "Postoperative complications among patients undergoing cardiac surgery"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1584.html" rel="external">
          "Early cardiac complications of coronary artery bypass graft surgery"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3921116846">
         <span class="h1">
          RISK FACTORS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The likelihood of cardiovascular instability due to hypotension, hypertension, or cardiac arrhythmias after noncardiac surgery is associated with various patient-associated and procedure associated factors, as noted in the tables  (
         <a class="graphic graphic_algorithm graphicRef117735" href="/z/d/graphic/117735.html" rel="external">
          algorithm 1
         </a>
         and
         <a class="graphic graphic_table graphicRef114577" href="/z/d/graphic/114577.html" rel="external">
          table 1
         </a>
         and
         <a class="graphic graphic_table graphicRef57828" href="/z/d/graphic/57828.html" rel="external">
          table 2
         </a>
         and
         <a class="graphic graphic_table graphicRef116645" href="/z/d/graphic/116645.html" rel="external">
          table 3
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Preoperative factors:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Severity of preexisting cardiovascular comorbidities (eg, ischemic heart disease, chronic hypertension, congestive heart failure, renal insufficiency, valvular heart disease, atrial and ventricular arrhythmias, peripheral vascular disease)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Recent stroke
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Recent placement of coronary artery stents
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Acute trauma (eg, hip fracture)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Urgent or emergency surgery
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intraoperative factors:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Invasiveness of the surgical procedure  (
         <a class="graphic graphic_table graphicRef116645" href="/z/d/graphic/116645.html" rel="external">
          table 3
         </a>
         ) [
         <a href="#rid4">
          4
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Severity of perioperative stresses (eg, blood loss, fluid shifts, sepsis, pain, hypothermia, hypotension)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Effects of anesthetic agents and techniques
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Postoperative factors:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Bleeding and/or hypovolemia
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hypoxemia
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pain
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H604297284">
         <span class="h1">
          HYPOTENSION
         </span>
        </p>
        <p class="headingAnchor" id="H30658124">
         <span class="h2">
          Initial assessment and treatment of hypotension
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Determining target values
         </strong>
         – Hypotension may be absolute (eg, systolic blood pressure [BP] &lt;90 mmHg or mean arterial pressure [MAP] &lt;65 mmHg) or relative (eg, systolic BP decrease &gt;20 percent of baseline). These values serve as a guide for treatment, although there is no widely accepted definition of perioperative hypotension [
         <a href="#rid5">
          5
         </a>
         ]. In general, rather than targeting a specific BP value, we attempt to maintain systolic BP values within 20 percent of the patient's baseline and MAP &gt;65 mmHg while the patient is in the PACU. Furthermore, low BP is treated if there is evidence of hypoperfusion (eg, change in mental status associated with lower blood pressure). (See
         <a class="medical medical_review" href="/z/d/html/94355.html" rel="external">
          "Anesthesia for patients with hypertension", section on 'Determination of target blood pressure values'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Also, diastolic "hypotension" is common in older patients since vascular aging leads to arterial rigidity causing isolated systolic hypertension with associated lowering of diastolic BP and widened pulse pressure. While clinical definitions of hypotension and management are typically based on systolic BP, it is prudent to also note the diastolic BP since organ perfusion occurs primarily during diastole.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Initial treatment
         </strong>
         – Initial treatment of hypotension in the PACU should be based on the etiology. Prior to initiating treatment, the accuracy of monitors should be assessed (see
         <a class="medical medical_review" href="/z/d/html/100067.html" rel="external">
          "Basic patient monitoring during anesthesia", section on 'Invasive blood pressure monitoring'
         </a>
         ). When hypovolemia (the most common cause) is suspected, management includes administration of intravenous (IV) isotonic crystalloid solution in 250- to 500-mL increments. If necessary, IV vasopressor/inotropic agents (eg,
         <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">
          phenylephrine
         </a>
         40- to 100-mcg increments or
         <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">
          ephedrine
         </a>
         5- to 10-mg increments) are also administered to rapidly increase BP.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment of severe or refractory hypotension
         </strong>
         – Small bolus doses of diluted IV
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         10 to 50 mcg,
         <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">
          norepinephrine
         </a>
         4 to 8 mcg, or
         <a class="drug drug_general" data-topicid="10039" href="/z/d/drug information/10039.html" rel="external">
          vasopressin
         </a>
         1 to 2 units may be administered while a vasopressor/inotropic infusion is prepared  (
         <a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">
          table 4
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Discharge disposition
         </strong>
         – Patients with refractory hypotension requiring continued treatment with vasopressors/inotropic therapy should be admitted to an inpatient setting for further observation, rather than discharged home. Diagnoses of myocardial infarction, decompensated heart failure, or other causes of potentially worsening hypotension should be ruled out. (See
         <a class="local">
          'Postoperative cardiovascular complications'
         </a>
         below and
         <a class="local">
          'Hypotensive emergencies'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H400336612">
         <span class="h2">
          Treatment of underlying causes of hypotension
         </span>
        </p>
        <p class="headingAnchor" id="H64268415">
         <span class="h3">
          Hypovolemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients undergoing major surgical procedures may develop intraoperative hypovolemia due to large fluid shifts or significant bleeding that has not been adequately corrected when the patient is admitted to the PACU. Other factors that may contribute to hypovolemia in the postoperative period include prolonged preoperative fasting, postoperative diuresis, ongoing postoperative fluid losses from the gastrointestinal tract, skin, or due to persistent unrecognized bleeding (eg, swallowed blood after tonsillectomy).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Assessment
         </strong>
         – The intraoperative records are reviewed to assess estimated blood loss and other perioperative fluid deficits and losses (eg, preoperative dehydration, intraoperative urine output) (see
         <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">
          "Intraoperative fluid management", section on 'Causes and consequences of intravascular volume derangements'
         </a>
         ). Also the amount and type of intraoperative fluid replacement therapy is noted. If available, central venous pressure (CVP) is measured to provide supplemental information regarding adequacy of intravascular volume, although CVP is poorly predictive of fluid responsiveness in most patients. (See
         <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">
          "Intraoperative fluid management", section on 'Traditional static parameters'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Since intraoperative blood loss is commonly underestimated, hemoglobin (Hgb) is measured if significant bleeding may have occurred. However, an individual Hgb value may not accurately reflect blood loss during or immediately after an acute bleeding episode. Also, bleeding may continue into the postoperative period due to circumstances that are case-specific (eg, delayed blood loss after knee surgery with intraoperative use of a tourniquet) or patient-specific (eg, preexisting coagulation disorders) [
         <a href="#rid6">
          6
         </a>
         ]. For these reasons, serial Hgb measurements are more useful than a single value.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
         – If there is evidence of inadequate fluid replacement, a balanced electrolyte crystalloid solution is administered in 250- to 500-mL IV boluses, with reassessment of intravascular volume status and BP after each bolus. (See
         <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">
          "Intraoperative fluid management", section on 'Choosing a fluid management strategy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Red blood cells (RBCs) are reserved until a transfusion threshold is met (typically when Hgb is &lt;7 to 8 g/dL or hematocrit is &lt;21 to 24 percent), similar to the intraoperative setting. However, patients with significant ongoing bleeding, known acute coronary syndrome, or signs of myocardial or other organ ischemia should receive RBC transfusion at a higher Hgb threshold (eg, &lt;9 g/dL or hematocrit &lt;27 percent). (See
         <a class="medical medical_review" href="/z/d/html/112610.html" rel="external">
          "Intraoperative transfusion and administration of clotting factors", section on 'Red blood cells'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7948.html" rel="external">
          "Indications and hemoglobin thresholds for RBC transfusion in adults", section on 'Thresholds for specific patient populations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In rare cases, significant hypotension may occur during transfusion of blood products due to an acute transfusion reaction  (
         <a class="graphic graphic_algorithm graphicRef96323" href="/z/d/graphic/96323.html" rel="external">
          algorithm 2
         </a>
         and
         <a class="graphic graphic_table graphicRef94399" href="/z/d/graphic/94399.html" rel="external">
          table 5
         </a>
         ). If this is suspected, the transfusion is stopped, IV fluids and vasopressor/inotropic agents are administered, and other standard treatments for such allergic reactions are initiated as appropriate  (
         <a class="graphic graphic_table graphicRef107933" href="/z/d/graphic/107933.html" rel="external">
          table 6
         </a>
         ). The blood bank should be notified if a transfusion reaction is suspected. (See
         <a class="medical medical_review" href="/z/d/html/95132.html" rel="external">
          "Approach to the patient with a suspected acute transfusion reaction"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H30658136">
         <span class="h3">
          Drug effects
         </span>
         <span class="headingEndMark">
          —
         </span>
         Review of preoperative medications, anesthetic techniques, and intraoperative drugs that were administered may suggest likely causes of postoperative hypotension.
        </p>
        <p class="headingAnchor" id="H3923590772">
         <span class="h4">
          Antihypertensive agents
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intraoperative or postoperative administration of longer-acting IV agents such as
         <a class="drug drug_general" data-topicid="8528" href="/z/d/drug information/8528.html" rel="external">
          hydralazine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9645" href="/z/d/drug information/9645.html" rel="external">
          metoprolol
         </a>
         , or
         <a class="drug drug_general" data-topicid="9540" href="/z/d/drug information/9540.html" rel="external">
          labetalol
         </a>
         may result in postoperative hypotension once painful surgical stimulation has ceased.
        </p>
        <p>
         Effects of chronically administered antihypertensive agents may cause hypotension during the intraoperative and/or postoperative periods. In particular, there is an increased risk of perioperative hypotension in patients taking angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs) preoperatively. The probable mechanism is inability to activate the sympathetic nervous system when intravascular volume is depleted. (See
         <a class="medical medical_review" href="/z/d/html/94355.html" rel="external">
          "Anesthesia for patients with hypertension", section on 'Antihypertensive medication management'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94355.html" rel="external">
          "Anesthesia for patients with hypertension", section on 'Inhibition of the renin angiotensin system'
         </a>
         .)
        </p>
        <p>
         As noted above, treatment includes careful volume expansion and/or administration of vasopressor/inotropic agents (see
         <a class="local">
          'Initial assessment and treatment of hypotension'
         </a>
         above). In some patients taking ACE inhibitors or ARBs, administration of
         <a class="drug drug_general" data-topicid="10039" href="/z/d/drug information/10039.html" rel="external">
          vasopressin
         </a>
         may be necessary to treat severe vasoplegia refractory to other medications  (
         <a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">
          table 4
         </a>
         ). An alternative treatment is administration of
         <a class="drug drug_general" data-topicid="9636" href="/z/d/drug information/9636.html" rel="external">
          methylene blue
         </a>
         1 to 2 mg/kg IV over 20 minutes to reduce resistance vessel responsiveness to nitric oxide.
        </p>
        <p>
         If a slow HR is contributing to hypotension due to the negative chronotropic effects of an antihypertensive agent, then it is also necessary to treat bradycardia. (See
         <a class="local">
          'Bradyarrhythmias'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3755762776">
         <span class="h4">
          Anesthetic agents
         </span>
         <span class="headingEndMark">
          —
         </span>
         Residual effects of anesthetic agents or excessive opioid doses may result in hypotension, particularly in patients who have little pain after surgery. Such patients are typically somnolent or obtunded, and may exhibit respiratory depression as well as hypotension. (See
         <a class="medical medical_review" href="/z/d/html/4401.html" rel="external">
          "Overview of the management of postoperative pulmonary complications"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Opioids
         </strong>
         – If excessive opioid dosing is suspected, small IV doses of
         <a class="drug drug_general" data-topicid="9678" href="/z/d/drug information/9678.html" rel="external">
          naloxone
         </a>
         40 to 80 mcg may be administered until opioid-related sedative and respiratory depressant effects are reversed  (
         <a class="graphic graphic_table graphicRef106215" href="/z/d/graphic/106215.html" rel="external">
          table 7
         </a>
         ). When opioids are the cause of persistent hypotension, the blood pressure should increase as the patient becomes more alert and has normal respiration.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In most patients, titration of low doses of
         <a class="drug drug_general" data-topicid="9678" href="/z/d/drug information/9678.html" rel="external">
          naloxone
         </a>
         safely reverses opioid effects. However, sudden reversal of analgesic effects may cause extreme discomfort and a sympathetic surge resulting in hypertension, tachycardia, and myocardial ischemia in susceptible patients (see
         <a class="local">
          'Myocardial injury'
         </a>
         below). Also, flash pulmonary edema has been reported after a large dose of naloxone in rare cases [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The half-life of
         <a class="drug drug_general" data-topicid="9678" href="/z/d/drug information/9678.html" rel="external">
          naloxone
         </a>
         is 1 to 1.5 hours, which may be shorter than the half-life of the opioid being reversed. In these cases, postoperative monitoring should continue because additional doses of naloxone may be required. (See
         <a class="medical medical_review" href="/z/d/html/300.html" rel="external">
          "Acute opioid intoxication in adults", section on 'Management'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Benzodiazepines
         </strong>
         – Oversedation with hypotension caused by benzodiazepines is uncommon in the postoperative setting. When this is suspected, IV
         <a class="drug drug_general" data-topicid="8456" href="/z/d/drug information/8456.html" rel="external">
          flumazenil
         </a>
         may be administered to reverse this effect  (
         <a class="graphic graphic_table graphicRef106215" href="/z/d/graphic/106215.html" rel="external">
          table 7
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/314.html" rel="external">
          "Benzodiazepine poisoning", section on 'Role of antidote (flumazenil)'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other agents
         </strong>
         – Intraoperative administration of
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         and/or inhalational anesthetic agents are unlikely to cause postoperative hypotension because of their brief duration of action. In contrast, intraoperative
         <a class="drug drug_general" data-topicid="8897" href="/z/d/drug information/8897.html" rel="external">
          dexmedetomidine
         </a>
         infusion, particularly at high doses, may cause hypotension in the postoperative period [
         <a href="#rid8">
          8,9
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/96308.html" rel="external">
          "Maintenance of general anesthesia: Overview", section on 'Dexmedetomidine'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H680092306">
         <span class="h3">
          Sympathectomy due to neuraxial block
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sympathectomy due to high neuraxial anesthetic block may result in hypotension, particularly if the sensory block is above the T6 level. Patients with preexisting hypertension may be at higher risk [
         <a href="#rid10">
          10
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/89517.html" rel="external">
          "Overview of neuraxial anesthesia", section on 'Cardiovascular'
         </a>
         .)
        </p>
        <p>
         If the neuraxial anesthetic includes a continuous infusion, this should be discontinued. In addition, hypotension is treated with vasopressor/inotropic agents (see
         <a class="local">
          'Initial assessment and treatment of hypotension'
         </a>
         above), and if hypovolemia is suspected, IV fluids are also administered. Also, the epidural catheter is aspirated to confirm that the catheter tip has not migrated into a blood vessel or the intrathecal space. If correct positioning of the catheter is confirmed, the neuraxial anesthetic infusion may be reinstituted using an opioid without local anesthetic in some patients. (See
         <a class="medical medical_review" href="/z/d/html/118479.html" rel="external">
          "Continuous epidural analgesia for postoperative pain: Technique and management", section on 'Hypotension'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H443893336">
         <span class="h3">
          Adrenal insufficiency
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acute adrenal insufficiency uncommonly occurs in a patient receiving chronic glucocorticoid therapy, but if corticosteroid replacement therapy is inadequate, this may be a cause of postoperative hypotension. This unusual cause of hypotension should be considered when hypotension is refractory to standard treatment with fluids and vasopressors in a patient with a history of chronic steroid therapy. Treatment includes IV
         <a class="drug drug_general" data-topicid="8535" href="/z/d/drug information/8535.html" rel="external">
          hydrocortisone
         </a>
         100 mg or
         <a class="drug drug_general" data-topicid="9334" href="/z/d/drug information/9334.html" rel="external">
          dexamethasone
         </a>
         4 mg. (See
         <a class="medical medical_review" href="/z/d/html/155.html" rel="external">
          "Treatment of adrenal insufficiency in adults", section on 'Adrenal crisis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3130962223">
         <span class="h2">
          Hypotensive emergencies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Certain conditions can cause profound hypotension and/or hemodynamic collapse requiring immediate lifesaving interventions. In the PACU setting, such conditions may include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hemorrhagic or nonhemorrhagic hypovolemic shock
         </strong>
         — Treatment is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/94164.html" rel="external">
          "Intraoperative management of shock in adults", section on 'Hypovolemic shock management'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Hemorrhage is the most common cause of hypovolemic shock in surgical patients. Nonhemorrhagic causes of severe hypovolemia in surgical patients include gastrointestinal losses (eg, vomiting, diarrhea, bowel preparation), skin losses (eg, burns), ascites, and prolonged surgery with an open abdominal cavity that may eventually lead to increased bowel edema and sequestration of fluid. (See
         <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">
          "Intraoperative fluid management", section on 'Causes and consequences of intravascular volume derangements'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Septic shock
         </strong>
         — Treatment is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/94164.html" rel="external">
          "Intraoperative management of shock in adults", section on 'Septic shock'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Sepsis is the most common cause of distributive shock in surgical patients, and may be preexisting before surgery, or may develop during or after surgery in patients with active infection. Sepsis should be suspected in susceptible patients with profound hypotension due to vasodilation (with high cardiac output if intravascular volume is adequate). After emergency management is initiated in the PACU, the surgeon and an infectious disease specialist are consulted to ensure that surgical causes have been addressed and that antibiotic coverage is appropriate and cultures have been sent. (See
         <a class="medical medical_review" href="/z/d/html/1613.html" rel="external">
          "Evaluation and management of suspected sepsis and septic shock in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anaphylactic shock
         </strong>
         — Treatment is based on prompt administration of IV
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         and fluid resuscitation, as well as other therapies, such as inhaled bronchodilators, IV steroids, and H1 and H2 antihistamines if symptoms persist. Treatment is discussed in detail in a separate topic  (
         <a class="graphic graphic_table graphicRef107933" href="/z/d/graphic/107933.html" rel="external">
          table 6
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/2077.html" rel="external">
          "Perioperative anaphylaxis: Clinical manifestations, etiology, and management", section on 'Initial management'
         </a>
         ). Steroids and H2 blockers should be included in the initial management of anaphylactic shock.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Severe postoperative hypotension may occur due to exposure to latex or a medication administered during or after surgery (eg, antibiotics, protamine)  (
         <a class="graphic graphic_table graphicRef60805" href="/z/d/graphic/60805.html" rel="external">
          table 8
         </a>
         ). Accompanying respiratory symptoms may include bronchospasm, inspiratory stridor, or oral edema. Allergic reactions typically present as itching, rash, or hives, but minor symptoms may not be noticed by a patient with residual postoperative sedation. (See
         <a class="medical medical_review" href="/z/d/html/2077.html" rel="external">
          "Perioperative anaphylaxis: Clinical manifestations, etiology, and management", section on 'Etiologies'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2077.html" rel="external">
          "Perioperative anaphylaxis: Clinical manifestations, etiology, and management", section on 'Clinical manifestations and diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cardiogenic shock
         </strong>
         — Treatment of cardiogenic shock complicating acute myocardial infarction (MI) is discussed separately  (
         <a class="graphic graphic_table graphicRef82406" href="/z/d/graphic/82406.html" rel="external">
          table 9
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/83.html" rel="external">
          "Prognosis and treatment of cardiogenic shock complicating acute myocardial infarction"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         MI is the most common perioperative cause of severe myocardial dysfunction, and cardiogenic shock may occur if &gt;40 percent of the myocardium is involved. Patients with ischemic heart disease are at risk, particularly if they had preoperative unstable angina, recent percutaneous coronary intervention, or emergency or high-risk surgery  (
         <a class="graphic graphic_table graphicRef57075" href="/z/d/graphic/57075.html" rel="external">
          table 10
         </a>
         ). (See
         <a class="local">
          'Myocardial injury'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Arrhythmogenic shock
         </strong>
         — Management of arrhythmogenic causes of shock is described in advanced cardiac life support protocols. (See
         <a class="medical medical_review" href="/z/d/html/278.html" rel="external">
          "Advanced cardiac life support (ACLS) in adults", section on 'Management of specific arrhythmias'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Local anesthetic systemic toxicity
         </strong>
         — Treatment is outlined in the table and discussed separately  (
         <a class="graphic graphic_table graphicRef107887" href="/z/d/graphic/107887.html" rel="external">
          table 11
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/90613.html" rel="external">
          "Local anesthetic systemic toxicity", section on 'Management of LAST'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/90613.html" rel="external">
          "Local anesthetic systemic toxicity", section on 'Lipid rescue'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Local anesthetic systemic toxicity (LAST) causing profound hypotension and arrhythmias (eg, tachycardia, bradycardia, ventricular arrhythmias, asystole) may occur in the postoperative period after dosing a catheter that is misplaced in an intravascular location. Rarely, accidental IV administration of a local anesthetic infusion intended for epidural or perineural administration may occur. (See
         <a class="medical medical_review" href="/z/d/html/94596.html" rel="external">
          "Prevention of perioperative medication errors", section on 'Wrong route errors'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/90613.html" rel="external">
          "Local anesthetic systemic toxicity", section on 'Risk factors for LAST'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Although the clinical presentation of LAST is highly variable, central nervous system symptoms (eg, perioral numbness, metallic taste, ringing in the ears, agitation, visual changes, muscle twitching, and ultimately, seizures) commonly precede signs of cardiovascular toxicity. (See
         <a class="medical medical_review" href="/z/d/html/90613.html" rel="external">
          "Local anesthetic systemic toxicity", section on 'Clinical presentation of toxicity'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tension pneumothorax
         </strong>
         — Treatment of suspected life-threatening tension pneumothorax does not require a chest radiograph before emergent needle decompression (using a 14 to 16 gauge IV catheter inserted in the second or third intercostal space in the midclavicular line) or emergent tube thoracostomy (using a 24 or 28 Fr tube inserted in the fifth intercostal space in the midaxillary line). (See
         <a class="medical medical_review" href="/z/d/html/98976.html" rel="external">
          "Evaluation of and initial approach to the adult patient with undifferentiated hypotension and shock", section on 'Tension pneumothorax'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7816.html" rel="external">
          "Thoracostomy tubes and catheters: Indications and tube selection in adults and children", section on 'Tension pneumothorax'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Tension pneumothorax should be suspected in patients with risk factors such as perioperative attempted or actual central line insertion, a surgical procedure that involved the neck or thorax, or chronic lung disease. In addition to hypotension, signs and symptoms include worsening oxygenation, dyspnea, tachypnea, unilateral diminished breath sounds and pleuritic chest pain, distended neck veins, and tracheal deviation away from the affected side.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pulmonary embolus
         </strong>
         — Pulmonary embolism is suspected in a hypotensive patient with acute onset of shortness of breath, tachycardia, and hypoxia. Treatment of patients who are hemodynamically unstable is discussed separately  (
         <a class="graphic graphic_algorithm graphicRef99762" href="/z/d/graphic/99762.html" rel="external">
          algorithm 3
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/8265.html" rel="external">
          "Treatment, prognosis, and follow-up of acute pulmonary embolism in adults", section on 'Hemodynamically unstable'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Left ventricular outflow tract obstruction
         </strong>
         — Immediate treatment of left ventricular outflow tract (LVOT) obstruction causing severe hypotension includes (see
         <a class="medical medical_review" href="/z/d/html/4920.html" rel="external">
          "Hypertrophic cardiomyopathy: Management of patients with outflow tract obstruction", section on 'Acute shock'
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Increasing left ventricular volume with fluid administration
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Increasing systemic vascular resistance with vasoconstrictors that do not have inotropic properties (eg,
         <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">
          phenylephrine
         </a>
         or
         <a class="drug drug_general" data-topicid="10039" href="/z/d/drug information/10039.html" rel="external">
          vasopressin
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Decreasing inotropy and heart rate (HR) with beta blockers
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In a susceptible patient with hypertrophic cardiomyopathy, dynamic LVOT obstruction can be precipitated by hypovolemia, vasodilation, tachycardia, and/or a high catecholamine state (eg, due to postoperative pain). Rapid diagnosis is possible with echocardiography. (See
         <a class="medical medical_review" href="/z/d/html/94296.html" rel="external">
          "Intraoperative rescue transesophageal echocardiography (TEE)", section on 'Left ventricular outflow tract obstruction'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H604297382">
         <span class="h1">
          HYPERTENSION
         </span>
        </p>
        <p class="headingAnchor" id="H30658945">
         <span class="h2">
          Initial assessment and treatment of hypertension
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Determining target values
         </strong>
         – Hypertension in the PACU is typically treated if systolic blood pressure (BP) is &gt;180 mmHg or diastolic BP is &gt;110 mmHg, particularly if hypertension persists after treatment of presumed etiologies. For patients who had severe preoperative hypertension (ie, ≥180/≥120 mmHg), treatment thresholds may differ. We review the patient's preoperative and baseline BP, as well as the home medication list and timing of last doses of antihypertensive medications. There is no known benefit from initiation of new therapy in the perioperative period to achieve normal BP values or goals appropriate for chronic control [
         <a href="#rid11">
          11
         </a>
         ]. Further management is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/94355.html" rel="external">
          "Anesthesia for patients with hypertension", section on 'Determination of target blood pressure values'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94355.html" rel="external">
          "Anesthesia for patients with hypertension", section on 'Acute postoperative hypertension'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Initial treatment
         </strong>
         – Prior to initiating treatment, the accuracy of monitors should be assessed (see
         <a class="medical medical_review" href="/z/d/html/100067.html" rel="external">
          "Basic patient monitoring during anesthesia", section on 'Invasive blood pressure monitoring'
         </a>
         ). Immediate treatment of the primary problem is necessary (see
         <a class="local">
          'Noxious stimuli'
         </a>
         below). In addition, small bolus doses of rapid-acting intravenous (IV) agents such as
         <a class="drug drug_general" data-topicid="9540" href="/z/d/drug information/9540.html" rel="external">
          labetalol
         </a>
         5 to 25 mg,
         <a class="drug drug_general" data-topicid="9645" href="/z/d/drug information/9645.html" rel="external">
          metoprolol
         </a>
         1 to 5 mg,
         <a class="drug drug_general" data-topicid="8528" href="/z/d/drug information/8528.html" rel="external">
          hydralazine
         </a>
         5 to 10 mg, or
         <a class="drug drug_general" data-topicid="9697" href="/z/d/drug information/9697.html" rel="external">
          nicardipine
         </a>
         0.2-mg increments may be titrated to decrease systolic BP to target values. Since metoprolol and labetalol have beta-blocking properties, these agents are preferred if hypertension is associated with tachycardia [
         <a href="#rid12">
          12,13
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment of severe or refractory hypertension
         </strong>
         – In some cases, continuous infusion of an antihypertensive agent may be necessary as the specific etiology is being treated  (
         <a class="graphic graphic_table graphicRef119750" href="/z/d/graphic/119750.html" rel="external">
          table 12
         </a>
         ). (See
         <a class="local">
          'Treatment of underlying causes of hypertension'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Discharge disposition
         </strong>
         – Patients with severe, refractory, or worsening hypertension should be admitted to an inpatient setting for further observation, rather than discharged home. Most patients who achieve hemodynamic stability after initial treatment, with stable BP within 20 percent of baseline values (typically &lt;160 systolic and &lt;100 diastolic) can be discharged home if this is otherwise appropriate. (See
         <a class="local">
          'Postoperative cardiovascular complications'
         </a>
         below and
         <a class="local">
          'Hypotensive emergencies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1047418413">
         <span class="h2">
          Hypertensive emergencies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Emergency treatment of severe hypertension is warranted if there is evidence of acute neurologic signs or symptoms (eg, agitation, delirium, stupor, visual disturbances, seizures, stroke) or a cardiovascular emergency (eg, acute coronary syndrome, acute decompensated heart failure, aortic dissection). In these instances, an IV antihypertensive agent(s) is immediately initiated while further workup is pursued  (
         <a class="graphic graphic_table graphicRef119750" href="/z/d/graphic/119750.html" rel="external">
          table 12
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/3837.html" rel="external">
          "Evaluation and treatment of hypertensive emergencies in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3840.html" rel="external">
          "Drugs used for the treatment of hypertensive emergencies"
         </a>
         .)
        </p>
        <p>
         Rarely, a pheochromocytoma may cause severe hypertension in the PACU, typically associated with tachycardia, arrhythmias, and/or cardiovascular collapse [
         <a href="#rid14">
          14-16
         </a>
         ]. Mortality risk is high. Treatment in the perioperative setting is described separately. (See
         <a class="medical medical_review" href="/z/d/html/94255.html" rel="external">
          "Anesthesia for the adult with pheochromocytoma", section on 'Treatment of hypertension and arrhythmias'
         </a>
         .)
        </p>
        <p>
         In a pregnant or postpartum woman, acute perioperative onset of severe hypertension with a systolic BP ≥160 mmHg or a diastolic BP ≥110 mmHg is a hypertensive emergency if these elevated BP values are accurately measured and persist &gt;15 minutes [
         <a href="#rid17">
          17
         </a>
         ]. Treatment in the perioperative setting for these patients is described separately. (See
         <a class="medical medical_review" href="/z/d/html/94355.html" rel="external">
          "Anesthesia for patients with hypertension", section on 'Management of hypertensive emergencies'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6815.html" rel="external">
          "Treatment of hypertension in pregnant and postpartum patients", section on 'Acute therapy of severe hypertension'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2480877850">
         <span class="h2">
          Treatment of underlying causes of hypertension
         </span>
        </p>
        <p class="headingAnchor" id="H416807755">
         <span class="h3">
          Preexisting hypertension
         </span>
         <span class="headingEndMark">
          —
         </span>
         Undiagnosed or poorly controlled preexisting hypertension is the most common cause of perioperative hypertension, particularly in patients receiving chronically administered antihypertensive medications that were not continued up until the time of surgery. Beta blockers and centrally acting sympatholytic drugs (eg,
         <a class="drug drug_general" data-topicid="9285" href="/z/d/drug information/9285.html" rel="external">
          clonidine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9635" href="/z/d/drug information/9635.html" rel="external">
          methyldopa
         </a>
         ) have been associated with severe acute withdrawal syndromes and perioperative hypertensive events. Postoperative hypertension is also more likely if an angiotensin converting enzyme (ACE) inhibitor or angiotensin II receptor blocker (ARB) is withheld on the day of surgery [
         <a href="#rid18">
          18
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3864.html" rel="external">
          "Tapering and discontinuing antihypertensive medications"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3868.html" rel="external">
          "Perioperative management of hypertension", section on 'Withdrawal syndromes'
         </a>
         .)
        </p>
        <p>
         Chronically administered oral antihypertensive therapy should be reinstituted as soon as possible in the postoperative period, or an IV equivalent may be administered if the patient cannot take oral medications. (See
         <a class="medical medical_review" href="/z/d/html/3864.html" rel="external">
          "Tapering and discontinuing antihypertensive medications"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3868.html" rel="external">
          "Perioperative management of hypertension", section on 'Withdrawal syndromes'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H604297388">
         <span class="h3">
          Noxious stimuli
         </span>
         <span class="headingEndMark">
          —
         </span>
         Noxious stimuli may cause marked sympathetic stimulation resulting in hypertension and tachycardia in the PACU. Hypertension and associated tachycardia typically resolve with appropriate treatment of the primary problem.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pain
         </strong>
         – (See
         <a class="medical medical_review" href="/z/d/html/130312.html" rel="external">
          "Approach to the management of acute pain in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nausea and/or vomiting
         </strong>
         – (See
         <a class="medical medical_review" href="/z/d/html/16849.html" rel="external">
          "Postoperative nausea and vomiting", section on 'Rescue therapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hypoxia and/or hypercarbia
         </strong>
         – (See
         <a class="medical medical_review" href="/z/d/html/94348.html" rel="external">
          "Respiratory problems in the post-anesthesia care unit (PACU)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Emergence delirium and agitation
         </strong>
         – (See
         <a class="medical medical_review" href="/z/d/html/93871.html" rel="external">
          "Delayed emergence and emergence delirium in adults", section on 'Emergence delirium'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hypothermia with shivering
         </strong>
         – Hypothermia results in sympathetic stimulation with hypertension and/or tachycardia causing increased myocardial oxygen consumption, particularly if shivering occurs [
         <a href="#rid19">
          19-21
         </a>
         ]. In a patient with ischemic heart disease, these effects can lead to myocardial ischemia and arrhythmias [
         <a href="#rid22">
          22
         </a>
         ]. (See
         <a class="local">
          'Myocardial injury'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/94588.html" rel="external">
          "Perioperative temperature management", section on 'Postoperative temperature derangements'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bladder distention
         </strong>
         – A distended bladder is a common and often overlooked cause of sympathetic stimulation causing hypertension in the PACU, particularly in patients with preexisting urinary retention, and in those who had a neuraxial block, excessive fluid administration, or certain types of surgery (eg, gynecologic, anorectal, hernia repair) [
         <a href="#rid23">
          23,24
         </a>
         ]. Management is described separately. (See
         <a class="medical medical_review" href="/z/d/html/14946.html" rel="external">
          "Overview of post-anesthetic care for adult patients", section on 'Inability to void'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Bladder or bowel distention in a patient with a high spinal cord injury (SCI) may cause autonomic dysreflexia, an exaggerated sympathetic response manifested by diffuse vasoconstriction below the level of SCI causing hypertension with bradycardia or tachycardia, and other symptoms. Management includes alleviation of the inciting cause, administration of oxygen, treatment of hypertension and arrhythmias, and assessment for myocardial ischemia. (See
         <a class="medical medical_review" href="/z/d/html/104423.html" rel="external">
          "Anesthesia for adults with chronic spinal cord injury", section on 'Autonomic dysreflexia'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/104423.html" rel="external">
          "Anesthesia for adults with chronic spinal cord injury", section on 'Management of intraoperative autonomic dysreflexia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H307120786">
         <span class="h3">
          Hypervolemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hypervolemia is suspected in patients who did not receive a dose of a chronically administered diuretic on the morning of surgery, if a large volume of irrigation solution was given into an organ cavity (eg, transurethral resection of the prostate, hysteroscopy), or if intraoperative fluid therapy was excessive. Intravascular volume status is best evaluated with dynamic hemodynamic parameters, as described separately. (See
         <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">
          "Intraoperative fluid management", section on 'Monitoring intravascular volume status'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Initial therapy is administration of an IV diuretic (typically
         <a class="drug drug_general" data-topicid="8482" href="/z/d/drug information/8482.html" rel="external">
          furosemide
         </a>
         20 to 40 mg), with vasodilator therapy (typically an infusion of IV
         <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">
          nitroglycerin
         </a>
         or
         <a class="drug drug_general" data-topicid="9707" href="/z/d/drug information/9707.html" rel="external">
          nitroprusside
         </a>
         (
         <a class="graphic graphic_table graphicRef119750" href="/z/d/graphic/119750.html" rel="external">
          table 12
         </a>
         )) as second-line treatment if hypervolemic hypertension is severe or associated with acute decompensated heart failure. (See
         <a class="local">
          'Decompensated heart failure'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H2408637533">
         <span class="h3">
          Drug effects
         </span>
        </p>
        <p class="headingAnchor" id="H924151517">
         <span class="h4">
          Alcohol or opioid withdrawal
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients chronically using alcohol or opioids may develop hypertension and/or tachycardia in the PACU due to sympathetic stimulation associated with withdrawal.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Alcohol withdrawal
         </strong>
         – Symptoms of alcohol withdrawal (eg, hypertension, tachycardia, tremulousness, sweating, nausea, anxiety) may manifest as early as 6 to 24 hours after the last drink, and can progress to delirium tremens with worsening hypertension in 48 to 96 hours. Benzodiazepines (eg, IV
         <a class="drug drug_general" data-topicid="9573" href="/z/d/drug information/9573.html" rel="external">
          lorazepam
         </a>
         ) are administered to treat withdrawal symptoms. Other aspects of management of alcohol withdrawal are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/323.html" rel="external">
          "Management of moderate and severe alcohol withdrawal syndromes"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Opioid withdrawal
         </strong>
         – Symptoms of opioid withdrawal include hypertension, as well as tachycardia, mydriasis, piloerection, nausea, and dysphoria  (
         <a class="graphic graphic_table graphicRef106994" href="/z/d/graphic/106994.html" rel="external">
          table 13
         </a>
         ). In chronic opioid users, postoperative hypertension may be exacerbated by inadequately treated pain due to opioid tolerance and/or opioid-induced hyperalgesia [
         <a href="#rid25">
          25,26
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/83726.html" rel="external">
          "Management of acute pain in the patient chronically using opioids for non-cancer pain"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H162977351">
         <span class="h4">
          Recent use of cocaine, amphetamine, phencyclidine, or MDMA
         </span>
         <span class="headingEndMark">
          —
         </span>
         Recent use of drugs that produce a hyperadrenergic state (eg, cocaine, amphetamine, phencyclidine, 3,4-methylenedioxymethamphetamine [MDMA], lysergic acid diethylamide [LSD], or monoamine oxidase inhibitors) can cause sympathetic overactivity and hypertension, tachycardia, and cardiac arrhythmias [
         <a href="#rid27">
          27
         </a>
         ]. Vasodilators such as
         <a class="drug drug_general" data-topicid="8528" href="/z/d/drug information/8528.html" rel="external">
          hydralazine
         </a>
         5 to 10 mg bolus doses or a continuous infusion of
         <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">
          nitroglycerin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9697" href="/z/d/drug information/9697.html" rel="external">
          nicardipine
         </a>
         , or
         <a class="drug drug_general" data-topicid="8911" href="/z/d/drug information/8911.html" rel="external">
          clevidipine
         </a>
         may be used to control hypertension in an acutely intoxicated patient  (
         <a class="graphic graphic_table graphicRef119750" href="/z/d/graphic/119750.html" rel="external">
          table 12
         </a>
         ). Beta-blockers (eg,
         <a class="drug drug_general" data-topicid="9645" href="/z/d/drug information/9645.html" rel="external">
          metoprolol
         </a>
         ,
         <a class="drug drug_general" data-topicid="9829" href="/z/d/drug information/9829.html" rel="external">
          propranolol
         </a>
         ,
         <a class="drug drug_general" data-topicid="9420" href="/z/d/drug information/9420.html" rel="external">
          esmolol
         </a>
         ) are relatively contraindicated in the treatment of hypertension in a patient who has recently used cocaine due to risk of inducing unopposed alpha-adrenergic stimulation [
         <a href="#rid27">
          27,28
         </a>
         ].
        </p>
        <p>
         An exaggerated severe hypertensive response or life-threatening dysrhythmias may occur after administration of any sympathomimetic agent (eg,
         <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">
          ephedrine
         </a>
         ) to a patient who has recently used any of these drugs. (See
         <a class="local">
          'Hypertensive emergencies'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/303.html" rel="external">
          "Cocaine: Acute intoxication", section on 'Cardiovascular complications'
         </a>
         .)
        </p>
        <p>
         Further details regarding management of hypertension and hemodynamic instability in patients intoxicated with substances of abuse are available in individual topics:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/82952.html" rel="external">
          "Acute amphetamine and synthetic cathinone ("bath salt") intoxication", section on 'Hypertension'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/313.html" rel="external">
          "Phencyclidine (PCP) intoxication in adults", section on 'Treatment of complications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/302.html" rel="external">
          "MDMA (ecstasy) intoxication", section on 'Cardiovascular stimulation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/302.html" rel="external">
          "MDMA (ecstasy) intoxication", section on 'Cardiac effects'
         </a>
         .):
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/317.html" rel="external">
          "Intoxication from LSD and other common hallucinogens"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H604297430">
         <span class="h1">
          CARDIAC ARRHYTHMIAS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Etiologies and acute management of postoperative cardiac arrhythmias are similar to the intraoperative setting, as discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/94357.html" rel="external">
          "Arrhythmias during anesthesia"
         </a>
         .)
        </p>
        <p>
         Most arrhythmias noted in the PACU are transient and clinically insignificant. If an arrhythmia persists in the PACU, proper lead placement for the electrocardiogram (ECG) should be confirmed and a 12-lead ECG should be obtained as soon as feasible. Stable waveforms from the pulse oximeter, intra-arterial catheter, and/or central venous catheter may be helpful to distinguish artifact from a true arrhythmia. (See
         <a class="medical medical_review" href="/z/d/html/100067.html" rel="external">
          "Basic patient monitoring during anesthesia", section on 'Sources of ECG artifact'
         </a>
         .)
        </p>
        <p>
         Causes of an arrhythmia should be identified and treated (eg, hypoxemia, hypoventilation, acidemia, anemia, electrolyte abnormalities)  (
         <a class="graphic graphic_table graphicRef52416" href="/z/d/graphic/52416.html" rel="external">
          table 14
         </a>
         ). In a patient with preexisting cardiovascular disease, the appearance of a new arrhythmia may indicate myocardial ischemia [
         <a href="#rid29">
          29
         </a>
         ]. (See
         <a class="local">
          'Myocardial injury'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1468388552">
         <span class="h2">
          Atrial tachycardias
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sinus tachycardia
         </strong>
         – Sinus tachycardia is a narrow complex regular tachycardia with heart rate (HR) &gt;100 beats per minute (bpm), and is relatively common in the PACU. The most likely potential causes include (see
         <a class="medical medical_review" href="/z/d/html/94357.html" rel="external">
          "Arrhythmias during anesthesia", section on 'Causes of sinus tachycardia'
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pain – Hypertension is typically also present (see
         <a class="local">
          'Noxious stimuli'
         </a>
         above).
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hypovolemia – Hypotension is typically also present (see
         <a class="local">
          'Hypovolemia'
         </a>
         above).
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Anemia – Hypotension is typically also present (see
         <a class="local">
          'Hypovolemia'
         </a>
         above).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Other possible causes include hypoxemia, hypercarbia, sepsis, fever, myocardial ischemia, pulmonary embolism, hyperthyroidism, and malignant hyperthermia.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Treatment of the underlying problem typically restores a normal HR. (See
         <a class="medical medical_review" href="/z/d/html/94357.html" rel="external">
          "Arrhythmias during anesthesia", section on 'Sinus tachycardia'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1074.html" rel="external">
          "Sinus tachycardia: Evaluation and management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Atrial fibrillation
         </strong>
         – Atrial fibrillation (AF) is a narrow complex irregular arrhythmia that may be chronic or occur with sudden onset during or shortly after surgery  (
         <a class="graphic graphic_waveform graphicRef73958" href="/z/d/graphic/73958.html" rel="external">
          waveform 1
         </a>
         ) [
         <a href="#rid30">
          30,31
         </a>
         ]. Common risk factors include preexisting AF or ischemic heart disease, while specific factors in the PACU include increased sympathetic activity due to stress of surgery, hypoxia, pain, acute anemia, or myocardial irritability caused by procedures performed near the heart (eg, pulmonary or esophageal surgery) [
         <a href="#rid30">
          30,31
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1014.html" rel="external">
          "The electrocardiogram in atrial fibrillation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Treatment of AF depends upon hemodynamic stability, as described separately  (
         <a class="graphic graphic_algorithm graphicRef130747" href="/z/d/graphic/130747.html" rel="external">
          algorithm 4
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/94357.html" rel="external">
          "Arrhythmias during anesthesia", section on 'Atrial fibrillation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/278.html" rel="external">
          "Advanced cardiac life support (ACLS) in adults", section on 'Tachycardia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Notably, patients with a preoperative history of atrial fibrillation have a higher risk of developing postoperative cardiovascular complications compared with those without [
         <a href="#rid32">
          32
         </a>
         ]. (See
         <a class="local">
          'Postoperative cardiovascular complications'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other atrial tachycardias
         </strong>
         – Treatment of other narrow QRS complex tachycardias that may occur in the PACU (eg, atrial flutter, atrioventricular [AV] node reentrant tachycardia, multifocal atrial tachycardia) or wide QRS complex tachycardias (eg, supraventricular tachycardia [SVT] with aberrant conduction, Wolff-Parkinson-White [WPW] syndrome) is similar to treatment in the intraoperative setting. (See
         <a class="medical medical_review" href="/z/d/html/94357.html" rel="external">
          "Arrhythmias during anesthesia", section on 'Wide QRS complex atrial tachyarrhythmias'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94357.html" rel="external">
          "Arrhythmias during anesthesia", section on 'Other narrow QRS complex atrial tachyarrhythmias'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3463601027">
         <span class="h2">
          Ventricular arrhythmias
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Premature ventricular contractions
         </strong>
         – Occasional, isolated premature ventricular contractions (PVCs) are relatively common in the PACU due to increased sympathetic stimulation  (
         <a class="graphic graphic_waveform graphicRef57511" href="/z/d/graphic/57511.html" rel="external">
          waveform 2
         </a>
         ); they typically resolve without treatment. Frequent new onset PVCs, however, warrant further observation since they can degenerate into dangerous arrhythmias. (See
         <a class="medical medical_review" href="/z/d/html/94357.html" rel="external">
          "Arrhythmias during anesthesia", section on 'Premature ventricular contractions'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/994.html" rel="external">
          "Premature ventricular complexes: Clinical presentation and diagnostic evaluation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Three or more consecutive ventricular beats at a rate &gt;120 bpm and lasting less than 30 seconds are considered to be nonsustained ventricular tachycardia (NSVT)  (
         <a class="graphic graphic_waveform graphicRef73299" href="/z/d/graphic/73299.html" rel="external">
          waveform 3
         </a>
         ). In some patients, frequent PVCs or NSVT may be evidence of myocardial ischemia. (See
         <a class="local">
          'Myocardial injury'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For hemodynamically stable patients with nonsustained VT who have a heart rate (HR) &gt;100 bpm a beta blocker or calcium channel blocker may be administered to reduce the ventricular rate while the patient is in the PACU  (
         <a class="graphic graphic_table graphicRef110671" href="/z/d/graphic/110671.html" rel="external">
          table 15
         </a>
         ).
         <a class="drug drug_general" data-topicid="8595" href="/z/d/drug information/8595.html" rel="external">
          Amiodarone
         </a>
         or class IB agents (eg,
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         ) may also be effective to maintain sinus rhythm. (See
         <a class="medical medical_review" href="/z/d/html/917.html" rel="external">
          "Nonsustained ventricular tachycardia: Clinical manifestations, evaluation, and management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Ventricular fibrillation and pulseless ventricular tachycardia
         </strong>
         – Ventricular fibrillation  (
         <a class="graphic graphic_waveform graphicRef118944" href="/z/d/graphic/118944.html" rel="external">
          waveform 4
         </a>
         ) should be treated immediately with defibrillation and advanced cardiac life support (ACLS)  (
         <a class="graphic graphic_algorithm graphicRef129983" href="/z/d/graphic/129983.html" rel="external">
          algorithm 5
         </a>
         ). A regular rhythm with a widened QRS complex (ie, monomorphic ventricular tachycardia [VT]  (
         <a class="graphic graphic_waveform graphicRef63176" href="/z/d/graphic/63176.html" rel="external">
          waveform 5
         </a>
         )) should also be treated immediately with defibrillation if there is no pulse, whereas VT with a pulse may be treated with synchronized cardioversion  (
         <a class="graphic graphic_algorithm graphicRef130747" href="/z/d/graphic/130747.html" rel="external">
          algorithm 4
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/278.html" rel="external">
          "Advanced cardiac life support (ACLS) in adults", section on 'Pulseless ventricular tachycardia and ventricular fibrillation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94357.html" rel="external">
          "Arrhythmias during anesthesia", section on 'Ventricular arrhythmias'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Polymorphic ventricular tachycardia (torsades de pointes)
         </strong>
         – Torsades de pointes (TdP) is an irregular polymorphic ventricular tachycardia  (
         <a class="graphic graphic_waveform graphicRef73827" href="/z/d/graphic/73827.html" rel="external">
          waveform 6
         </a>
         and
         <a class="graphic graphic_waveform graphicRef60231" href="/z/d/graphic/60231.html" rel="external">
          waveform 7
         </a>
         ). Management includes prompt defibrillation in a hemodynamically unstable patient, as in the intraoperative setting. (See
         <a class="medical medical_review" href="/z/d/html/936.html" rel="external">
          "Overview of the acute management of tachyarrhythmias", section on 'Polymorphic ventricular tachycardia'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94357.html" rel="external">
          "Arrhythmias during anesthesia", section on 'Polymorphic ventricular tachycardia (torsades de pointes)'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Certain agents that are commonly administered in the PACU and perioperative period (eg,
         <a class="drug drug_general" data-topicid="9623" href="/z/d/drug information/9623.html" rel="external">
          methadone
         </a>
         ,
         <a class="drug drug_general" data-topicid="9395" href="/z/d/drug information/9395.html" rel="external">
          droperidol
         </a>
         ,
         <a class="drug drug_general" data-topicid="9719" href="/z/d/drug information/9719.html" rel="external">
          ondansetron
         </a>
         ) may prolong the QT interval and increase risk for TdP and malignant ventricular arrhythmias  (
         <a class="graphic graphic_table graphicRef117757" href="/z/d/graphic/117757.html" rel="external">
          table 16
         </a>
         ). These agents are avoided in patients with known prolonged QT interval. (See
         <a class="medical medical_review" href="/z/d/html/94357.html" rel="external">
          "Arrhythmias during anesthesia", section on 'Medications that may prolong the QT interval'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Methadone
         </strong>
         –
         <a class="drug drug_general" data-topicid="9623" href="/z/d/drug information/9623.html" rel="external">
          Methadone
         </a>
         administered in large doses prolongs the QT interval and has been linked with TdP [
         <a href="#rid33">
          33,34
         </a>
         ]. Patients receiving chronic methadone therapy should have a preoperative baseline ECG before receiving any other perioperative medications that may further prolong the QT interval.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Droperidol
         </strong>
         <strong>
          and
         </strong>
         <strong>
          haloperidol
         </strong>
         – Low doses of the butyrophenone antiemetic agents
         <a class="drug drug_general" data-topicid="8516" href="/z/d/drug information/8516.html" rel="external">
          haloperidol
         </a>
         and
         <a class="drug drug_general" data-topicid="9395" href="/z/d/drug information/9395.html" rel="external">
          droperidol
         </a>
         are used for prophylaxis or management of postoperative nausea and vomiting (PONV); however, these agents are associated with an increase in the QT interval and should be avoided in patients with preexisting QT prolongation [
         <a href="#rid35">
          35,36
         </a>
         ]. The US Food and Drug Administration (FDA) issued a boxed warning for droperidol regarding the potential for sudden cardiac death with its use. (See
         <a class="medical medical_review" href="/z/d/html/16849.html" rel="external">
          "Postoperative nausea and vomiting", section on 'Antidopaminergics'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Ondansetron
         </strong>
         – The serotonin antagonists (
         <a class="drug drug_general" data-topicid="9719" href="/z/d/drug information/9719.html" rel="external">
          ondansetron
         </a>
         ,
         <a class="drug drug_general" data-topicid="8501" href="/z/d/drug information/8501.html" rel="external">
          granisetron
         </a>
         , and, outside the United States,
         <a class="drug drug_general" data-topicid="8592" href="/z/d/drug information/8592.html" rel="external">
          dolasetron
         </a>
         , ramosetron, and tropisetron) may prolong the QT interval and should be avoided in a patient with preexisting QT prolongation. (See
         <a class="medical medical_review" href="/z/d/html/16849.html" rel="external">
          "Postoperative nausea and vomiting", section on 'Serotonin (5-hydroxytryptamine) receptor antagonists'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Other causes and potentiators of long QT syndrome are listed in the table  (
         <a class="graphic graphic_table graphicRef57431" href="/z/d/graphic/57431.html" rel="external">
          table 17
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1409962282">
         <span class="h2">
          Bradyarrhythmias
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Initial assessment and treatment
         </strong>
         – Mild sinus bradycardia (ie, HR 40 to 60 bpm) that remains stable in an asymptomatic patient and is not associated with major alterations in blood pressure [BP]) does not require treatment, and is relatively common in the PACU setting. Comparison with the patient's preoperative HR is necessary prior to initiating treatment. (See
         <a class="medical medical_review" href="/z/d/html/1075.html" rel="external">
          "Sinus bradycardia"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Moderate bradycardia in a patient with mild symptoms may be initially treated with intravenous (IV)
         <a class="drug drug_general" data-topicid="8496" href="/z/d/drug information/8496.html" rel="external">
          glycopyrrolate
         </a>
         in 0.2 mg increments up to 1 mg and/or
         <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">
          ephedrine
         </a>
         in 5 to 10 mg increments.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Severe bradycardia (HR &lt;40 bpm) in a patient who is symptomatic (eg, altered mental status) or unstable (eg, hypotension) is treated with IV
         <a class="drug drug_general" data-topicid="8983" href="/z/d/drug information/8983.html" rel="external">
          atropine
         </a>
         0.5 mg, and this dose may be repeated every three to five minutes up to a total of 3 mg  (
         <a class="graphic graphic_algorithm graphicRef130748" href="/z/d/graphic/130748.html" rel="external">
          algorithm 6
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Further management of severe sinus bradycardia, sinus node dysfunction, bundle branch blocks, or conduction defects may include positive chronotropic agents and/or temporary pacing, as discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/278.html" rel="external">
          "Advanced cardiac life support (ACLS) in adults", section on 'Bradycardia'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94357.html" rel="external">
          "Arrhythmias during anesthesia", section on 'Sinus bradycardia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Assessment and treatment of underlying causes
         </strong>
         – Assessment for the possibility of the following potential causes of bradyarrhythmias is necessary in the PACU setting:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Medications
         </strong>
         – Negative chronotropic agents administered in the perioperative period (eg, beta blockers, calcium channel blockers,
         <a class="drug drug_general" data-topicid="9360" href="/z/d/drug information/9360.html" rel="external">
          digoxin
         </a>
         ,
         <a class="drug drug_general" data-topicid="8595" href="/z/d/drug information/8595.html" rel="external">
          amiodarone
         </a>
         ), anticholinesterase agents used to reverse the effects of a nondepolarizing neuromuscular blocking agent (NMBA) near the end of a surgical procedure, large bolus doses of an opioid, or a reflex response to hypertension caused by administration of a large dose of a vasoconstrictor agent (eg,
         <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">
          phenylephrine
         </a>
         ) may all cause bradycardia. (See
         <a class="medical medical_review" href="/z/d/html/94357.html" rel="external">
          "Arrhythmias during anesthesia", section on 'Sinus bradycardia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Neuraxial anesthesia
         </strong>
         – Neuraxial anesthesia with a T1 to T4 anesthetic level may cause sinus bradycardia as well as associated hypotension. If an epidural infusion is being administered, it should be temporarily discontinued. Although
         <a class="drug drug_general" data-topicid="8983" href="/z/d/drug information/8983.html" rel="external">
          atropine
         </a>
         may be effective, bradycardia caused by neuraxial anesthetic blockade of the cardiac accelerator fibers responds best to beta-adrenergic agonists (eg,
         <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">
          ephedrine
         </a>
         5 to 10 mg or, if severe or persistent,
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         10 to 20 mcg, titrated to effect, then followed by an epinephrine infusion  (
         <a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">
          table 4
         </a>
         )). (See
         <a class="medical medical_review" href="/z/d/html/94357.html" rel="external">
          "Arrhythmias during anesthesia", section on 'Sinus bradycardia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Bowel or bladder distention
         </strong>
         – Visceral distention of the bowel or bladder may initiate a vagal reflex, causing sinus bradycardia. (See
         <a class="medical medical_review" href="/z/d/html/14946.html" rel="external">
          "Overview of post-anesthetic care for adult patients", section on 'Inability to void'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         In a patient with a high spinal cord injury (SCI), bowel or bladder distention may cause autonomic dysreflexia, an exaggerated sympathetic response manifested by diffuse vasoconstriction below the level of SCI causing hypertension with bradycardia (or tachycardia). (See
         <a class="local">
          'Noxious stimuli'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/104423.html" rel="external">
          "Anesthesia for adults with chronic spinal cord injury", section on 'Management of intraoperative autonomic dysreflexia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Respiratory problems
         </strong>
         – Hypoxemia may cause bradycardia. (See
         <a class="medical medical_review" href="/z/d/html/94348.html" rel="external">
          "Respiratory problems in the post-anesthesia care unit (PACU)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Myocardial ischemia
         </strong>
         – Sinus bradycardia occurs in 15 to 25 percent of patients having an acute myocardial infarction, particularly if ischemia involves the right coronary artery. (See
         <a class="local">
          'Myocardial injury'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/82.html" rel="external">
          "Supraventricular arrhythmias after myocardial infarction", section on 'Sinus bradycardia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H389674426">
         <span class="h1">
          POSTOPERATIVE CARDIOVASCULAR COMPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Surgery may precipitate complications such as myocardial infarction or injury, cardiac arrest, congestive heart failure, or death from cardiac causes [
         <a href="#rid37">
          37,38
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H389674433">
         <span class="h2">
          Myocardial injury
         </span>
         <span class="headingEndMark">
          —
         </span>
         Prevention, early recognition, and prompt treatment of myocardial injury after noncardiac surgery (MINS) are critically important [
         <a href="#rid38">
          38-40
         </a>
         ]. Continuous electrocardiography (ECG) monitoring is employed for all patients in the PACU. If available, multiple leads (eg, II and V
         <sub>
          5
         </sub>
         ) and computerized ST-segment analysis are employed in patients with risk factors for myocardial ischemia after noncardiac surgery  (
         <a class="graphic graphic_table graphicRef57075" href="/z/d/graphic/57075.html" rel="external">
          table 10
         </a>
         and
         <a class="graphic graphic_table graphicRef57828" href="/z/d/graphic/57828.html" rel="external">
          table 2
         </a>
         and
         <a class="graphic graphic_table graphicRef116645" href="/z/d/graphic/116645.html" rel="external">
          table 3
         </a>
         ) [
         <a href="#rid41">
          41
         </a>
         ]. MINS is usually asymptomatic, but is a leading cause of postoperative death [
         <a href="#rid37">
          37,38,40,42
         </a>
         ]. Approximately 40 percent of MINS occurs on the day of surgery [
         <a href="#rid40">
          40
         </a>
         ]. Thus, a 12-lead ECG and, most importantly, troponin measurements are obtained for patients at high risk [
         <a href="#rid38">
          38-40,43
         </a>
         ]. A cardiologist is consulted for any patient with symptoms or signs suggestive of myocardial ischemia since urgent subspecialist interventions may be necessary if an acute coronary syndrome is developing  (
         <a class="graphic graphic_table graphicRef75032" href="/z/d/graphic/75032.html" rel="external">
          table 18
         </a>
         ). Recommendations for postoperative management of MINS are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/69.html" rel="external">
          "Perioperative myocardial infarction or injury after noncardiac surgery", section on 'Acute treatment'
         </a>
         .)
        </p>
        <p>
         Postoperative hypotension is strongly associated with MINS, particularly if prolonged or severe, and should be detected and promptly treated [
         <a href="#rid40">
          40,44
         </a>
         ]. Acute postoperative pain and tachycardia have also been associated with MINS [
         <a href="#rid45">
          45,46
         </a>
         ]. Furthermore, hypothermia results in sympathetic stimulation with hypertension and/or tachycardia causing increased myocardial oxygen consumption, particularly with shivering [
         <a href="#rid19">
          19,21,22
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/94588.html" rel="external">
          "Perioperative temperature management", section on 'Postoperative temperature derangements'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94588.html" rel="external">
          "Perioperative temperature management", section on 'Shivering'
         </a>
         ). Optimal myocardial oxygen (O
         <sub>
          2
         </sub>
         ) supply and minimal O
         <sub>
          2
         </sub>
         demand are achieved by maintaining normal to high blood pressure (BP), low to normal heart rate (HR), euvolemia, and normothermia  (
         <a class="graphic graphic_table graphicRef91907" href="/z/d/graphic/91907.html" rel="external">
          table 19
         </a>
         ) [
         <a href="#rid19">
          19,21,22,40,44,45
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/90616.html" rel="external">
          "Anesthesia for noncardiac surgery in patients with ischemic heart disease", section on 'Postoperative management'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H851427634">
         <span class="h2">
          Decompensated heart failure
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients at increased risk for development of acute decompensated heart failure (HF) in the immediate postoperative period include those with a history of HF (with reduced or preserved ejection fraction). Perioperative exacerbation of chronic HF may occur due to excessive intraoperative fluid administration, prolonged unfavorable surgical positioning (eg, supine positioning of a patient who cannot tolerate this position while awake), myocardial ischemia, or stress-induced (Takotsubo) cardiomyopathy. (See
         <a class="medical medical_review" href="/z/d/html/91654.html" rel="external">
          "Intraoperative management for noncardiac surgery in patients with heart failure"
         </a>
         .)
        </p>
        <p>
         Acute postoperative decompensated HF typically manifests as respiratory distress with or without pulmonary edema, and may be accompanied by hypertension due to hypervolemia or hypotension in a patient with cardiogenic shock. Any patient with evidence of pulmonary edema should be evaluated for new or unstable myocardial ischemia including cardiac monitoring, ECG, and serial cardiac enzyme measurements. Other treatment of acute decompensated HF in the PACU setting includes  (
         <a class="graphic graphic_table graphicRef75041" href="/z/d/graphic/75041.html" rel="external">
          table 20
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/105407.html" rel="external">
          "Perioperative management of heart failure in patients undergoing noncardiac surgery", section on 'Postoperative management'
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Administration of supplemental O
         <sub>
          2
         </sub>
         . Persistent respiratory distress and/or hypoxemia despite oxygen therapy is treated with either a trial of noninvasive ventilation (NIV) or endotracheal intubation and mechanical ventilation as appropriate in this clinical setting. (See
         <a class="medical medical_review" href="/z/d/html/3450.html" rel="external">
          "Treatment of acute decompensated heart failure: Specific therapies", section on 'Supplemental oxygen and assisted ventilation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1636.html" rel="external">
          "Noninvasive ventilation in adults with acute respiratory failure: Benefits and contraindications", section on 'Acute cardiogenic pulmonary edema (ACPE)'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For pulmonary edema or fluid overload, intravenous (IV) diuretics are administered. (See
         <a class="medical medical_review" href="/z/d/html/3450.html" rel="external">
          "Treatment of acute decompensated heart failure: Specific therapies", section on 'Diuretics'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Initiation of vasodilator therapy in the following settings: early IV
         <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">
          nitroglycerin
         </a>
         as a component of therapy in patients with refractory HF (eg, inadequate response to diuretics and/or low cardiac output), or IV arterial vasodilator therapy to reduce afterload in patients with severe hypertension  (
         <a class="graphic graphic_table graphicRef119750" href="/z/d/graphic/119750.html" rel="external">
          table 12
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/3450.html" rel="external">
          "Treatment of acute decompensated heart failure: Specific therapies", section on 'Vasodilator therapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients with known HF with reduced ejection fraction and developing signs of cardiogenic shock, management includes infusion of an inotrope (eg,
         <a class="drug drug_general" data-topicid="9652" href="/z/d/drug information/9652.html" rel="external">
          milrinone
         </a>
         or
         <a class="drug drug_general" data-topicid="9380" href="/z/d/drug information/9380.html" rel="external">
          dobutamine
         </a>
         ), in combination with a vasopressor if necessary to maintain systemic BP (eg,
         <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">
          norepinephrine
         </a>
         (
         <a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">
          table 4
         </a>
         )). Inotropes are
         <strong>
          not
         </strong>
         indicated for treatment of HF with preserved ejection fraction. (See
         <a class="medical medical_review" href="/z/d/html/3450.html" rel="external">
          "Treatment of acute decompensated heart failure: Specific therapies", section on 'Inotropic agents'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Consultation with a cardiologist or other specialist (eg, an intensivist) to arrange transfer to an intensive care unit and further management. (See
         <a class="medical medical_review" href="/z/d/html/3450.html" rel="external">
          "Treatment of acute decompensated heart failure: Specific therapies", section on 'Approach to long-term therapy in hospitalized patients'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2854599143">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk factors
         </strong>
         – The likelihood of cardiovascular instability due to hypotension, hypertension, or cardiac arrhythmias after noncardiac surgery is associated with various patient-associated and procedure associated factors, as noted in the tables  (
         <a class="graphic graphic_algorithm graphicRef117735" href="/z/d/graphic/117735.html" rel="external">
          algorithm 1
         </a>
         and
         <a class="graphic graphic_table graphicRef114577" href="/z/d/graphic/114577.html" rel="external">
          table 1
         </a>
         and
         <a class="graphic graphic_table graphicRef57828" href="/z/d/graphic/57828.html" rel="external">
          table 2
         </a>
         and
         <a class="graphic graphic_table graphicRef116645" href="/z/d/graphic/116645.html" rel="external">
          table 3
         </a>
         ). (See
         <a class="local">
          'Risk factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hypotension
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Definition and initial treatment
         </strong>
         – Hypotension in the post-anesthesia care unit (PACU) is typically treated if systolic blood pressure (BP) &lt;90 mmHg, mean arterial pressure (MAP) &lt;65 mmHg, or relative changes are significant (eg, systolic BP decrease &gt;20 percent of baseline). Accuracy of measured BP values is ensured before initial treatment with intravenous (IV) isotonic crystalloid solution administered in 250- to 500-mL increments, and IV vasopressor/inotropic agents as needed (eg,
         <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">
          phenylephrine
         </a>
         40- to 100-mcg increments or
         <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">
          ephedrine
         </a>
         5- to 10-mg increments). For severe or refractory hypotension, small bolus doses of diluted IV
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         10 to 50 mcg,
         <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">
          norepinephrine
         </a>
         4 to 8 mcg, or
         <a class="drug drug_general" data-topicid="10039" href="/z/d/drug information/10039.html" rel="external">
          vasopressin
         </a>
         1 to 2 units may be administered while a vasopressor/inotropic infusion is prepared  (
         <a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">
          table 4
         </a>
         ). (See
         <a class="local">
          'Initial assessment and treatment of hypotension'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Treat causes
         </strong>
         – Underlying causes of hypotension include hypovolemia, drug effects (eg, antihypertensive agents, anesthetic agents), sympathectomy due to neuraxial blockade, or adrenal insufficiency. (See
         <a class="local">
          'Treatment of underlying causes of hypotension'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Treatment of severe hypotension
         </strong>
         – Severe hypotension or hemodynamic collapse requiring immediate lifesaving intervention may occur due to hemorrhagic or nonhemorrhagic shock, septic shock, anaphylactic shock, cardiogenic shock, arrhythmogenic shock, local anesthetic systemic toxicity, tension pneumothorax, pulmonary embolus, or dynamic left ventricular outflow tract obstruction. (See
         <a class="local">
          'Hypotensive emergencies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hypertension
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Definition and initial treatment
         </strong>
         – Hypertension in the PACU is typically treated if systolic BP is &gt;180 mmHg or diastolic BP is &gt;110 mmHg; thresholds for patients who had severe preoperative hypertension (ie, ≥180/≥120 mmHg) may differ. (See
         <a class="local">
          'Initial assessment and treatment of hypertension'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Treat causes
         </strong>
         – Underlying causes of hypertension include missed doses of chronically administered antihypertensive medications, noxious stimuli (eg, pain, nausea and/or vomiting, hypoxia and/or hypercarbia, agitation, hypothermia with shivering, bladder distention), hypervolemia, alcohol or opioid withdrawal, or recent use of drugs that produce a hyperadrenergic state such as cocaine, amphetamine, phencyclidine, lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (MDMA), or monoamine oxidase inhibitors. (See
         <a class="local">
          'Treatment of underlying causes of hypertension'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Treatment of severe hypertension
         </strong>
         – Emergency treatment of severe hypertension is warranted if there is evidence of acute neurologic signs or symptoms (eg, agitation, delirium, stupor, visual disturbances, seizures, stroke) or cardiovascular emergency (eg, acute coronary syndrome, acute decompensated heart failure, aortic dissection). In these instances, an IV antihypertensive agent(s) is immediately initiated while further workup is pursued  (
         <a class="graphic graphic_table graphicRef119750" href="/z/d/graphic/119750.html" rel="external">
          table 12
         </a>
         ). (See
         <a class="local">
          'Hypertensive emergencies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Arrhythmias
         </strong>
         – Most arrhythmias noted in the PACU are transient and clinically insignificant. For persistent arrhythmias, proper lead placement for the electrocardiogram (ECG) should be confirmed, a 12-lead ECG should be obtained, and causes contributing to persistence of an arrhythmia should be identified and treated (eg, hypoxemia, hypoventilation, acidemia, anemia, electrolyte abnormalities)  (
         <a class="graphic graphic_table graphicRef52416" href="/z/d/graphic/52416.html" rel="external">
          table 14
         </a>
         ). Acute management of postoperative cardiac arrhythmias is similar to that in the intraoperative setting. (See
         <a class="local">
          'Cardiac arrhythmias'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/94357.html" rel="external">
          "Arrhythmias during anesthesia"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Postoperative cardiovascular complications
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Myocardial injury
         </strong>
         – Myocardial injury after noncardiac surgery (MINS) is a leading cause of postoperative death. Thus, a 12-lead ECG and troponin measurements are obtained for patients at high risk  (
         <a class="graphic graphic_table graphicRef57075" href="/z/d/graphic/57075.html" rel="external">
          table 10
         </a>
         and
         <a class="graphic graphic_table graphicRef57828" href="/z/d/graphic/57828.html" rel="external">
          table 2
         </a>
         and
         <a class="graphic graphic_table graphicRef116645" href="/z/d/graphic/116645.html" rel="external">
          table 3
         </a>
         ). Optimal myocardial oxygen (O
         <sub>
          2
         </sub>
         ) supply and minimal O
         <sub>
          2
         </sub>
         demand are achieved by maintaining normal to high BP, low to normal heart rate (HR), normothermia, and euvolemia, as well as avoiding or treating postoperative pain  (
         <a class="graphic graphic_table graphicRef91907" href="/z/d/graphic/91907.html" rel="external">
          table 19
         </a>
         ). (See
         <a class="local">
          'Myocardial injury'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/69.html" rel="external">
          "Perioperative myocardial infarction or injury after noncardiac surgery"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Decompensated heart failure
         </strong>
         – Acute postoperative decompensated heart failure (HF) typically manifests as respiratory distress with or without pulmonary edema, and may be accompanied by hypertension due to hypervolemia or hypotension in a patient with cardiogenic shock. Any patient with evidence of pulmonary edema should be evaluated for new or unstable myocardial ischemia including cardiac monitoring, ECG, and serial cardiac enzyme measurements. Diagnosis and treatment of acute decompensated HF are noted in the table and discussed separately  (
         <a class="graphic graphic_table graphicRef75041" href="/z/d/graphic/75041.html" rel="external">
          table 20
         </a>
         ). (See
         <a class="local">
          'Decompensated heart failure'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/105407.html" rel="external">
          "Perioperative management of heart failure in patients undergoing noncardiac surgery", section on 'Postoperative management'
         </a>
         .)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Hines R, Barash PG, Watrous G, O'Connor T. Complications occurring in the postanesthesia care unit: a survey. Anesth Analg 1992; 74:503.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rose DK, Cohen MM, DeBoer DP. Cardiovascular events in the postanesthesia care unit: contribution of risk factors. Anesthesiology 1996; 84:772.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kluger MT, Bullock MF. Recovery room incidents: a review of 419 reports from the Anaesthetic Incident Monitoring Study (AIMS). Anaesthesia 2002; 57:1060.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu JB, Liu Y, Cohen ME, et al. Defining the Intrinsic Cardiac Risks of Operations to Improve Preoperative Cardiac Risk Assessments. Anesthesiology 2018; 128:283.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bijker JB, van Klei WA, Kappen TH, et al. Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology 2007; 107:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Solon JG, Egan C, McNamara DA. Safe surgery: how accurate are we at predicting intra-operative blood loss? J Eval Clin Pract 2013; 19:100.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taff RH. Pulmonary edema following naloxone administration in a patient without heart disease. Anesthesiology 1983; 59:576.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dutta A, Sethi N, Sood J, et al. The Effect of Dexmedetomidine on Propofol Requirements During Anesthesia Administered by Bispectral Index-Guided Closed-Loop Anesthesia Delivery System: A Randomized Controlled Study. Anesth Analg 2019; 129:84.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Colin PJ, Hannivoort LN, Eleveld DJ, et al. Dexmedetomidine pharmacodynamics in healthy volunteers: 2. Haemodynamic profile. Br J Anaesth 2017; 119:211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klasen J, Junger A, Hartmann B, et al. Differing incidences of relevant hypotension with combined spinal-epidural anesthesia and spinal anesthesia. Anesth Analg 2003; 96:1491.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018; 71:e13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lonjaret L, Lairez O, Minville V, Geeraerts T. Optimal perioperative management of arterial blood pressure. Integr Blood Press Control 2014; 7:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aronson S, Varon J. Hemodynamic control and clinical outcomes in the perioperative setting. J Cardiothorac Vasc Anesth 2011; 25:509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Myklejord DJ. Undiagnosed pheochromocytoma: the anesthesiologist nightmare. Clin Med Res 2004; 2:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sheinberg R, Gao WD, Wand G, et al. Case 1--2012. A perfect storm: fatality resulting from metoclopramide unmasking a pheochromocytoma and its management. J Cardiothorac Vasc Anesth 2012; 26:161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Riordan JA. Pheochromocytomas and anesthesia. Int Anesthesiol Clin 1997; 35:99.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Podovei M, Bateman BT. The Consensus Bundle on Hypertension in Pregnancy and the Anesthesiologist: Doing All the Right Things for All the Patients All of the Time. Anesth Analg 2017; 125:383.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vassallo MC, Tartamella F, Testa F. To Stop Or Not? Withholding Anti-hypertensive Therapy Before Surgery Is Not Safe. J Cardiothorac Vasc Anesth 2017; 31:e92.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frank SM, Fleisher LA, Olson KF, et al. Multivariate determinants of early postoperative oxygen consumption in elderly patients. Effects of shivering, body temperature, and gender. Anesthesiology 1995; 83:241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sun KO. Severe postoperative shivering and hypoglycaemia. Anaesth Intensive Care 1993; 21:873.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Witte J, Sessler DI. Perioperative shivering: physiology and pharmacology. Anesthesiology 2002; 96:467.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frank SM, Fleisher LA, Breslow MJ, et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. A randomized clinical trial. JAMA 1997; 277:1127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baldini G, Bagry H, Aprikian A, Carli F. Postoperative urinary retention: anesthetic and perioperative considerations. Anesthesiology 2009; 110:1139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dal Mago AJ, Helayel PE, Bianchini E, et al. Prevalence and predictive factors of urinary retention assessed by ultrasound in the immediate post-anesthetic period. Rev Bras Anestesiol 2010; 60:383.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vadivelu N, Mitra S, Kaye AD, Urman RD. Perioperative analgesia and challenges in the drug-addicted and drug-dependent patient. Best Pract Res Clin Anaesthesiol 2014; 28:91.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pulley DD. Preoperative Evaluation of the Patient with Substance Use Disorder and Perioperative Considerations. Anesthesiol Clin 2016; 34:201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hernandez M, Birnbach DJ, Van Zundert AA. Anesthetic management of the illicit-substance-using patient. Curr Opin Anaesthesiol 2005; 18:315.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med 2001; 345:351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ghadimi K, Thompson A. Update on perioperative care of the cardiac patient for noncardiac surgery. Curr Opin Anaesthesiol 2015; 28:342.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhave PD, Goldman LE, Vittinghoff E, et al. Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery. Am Heart J 2012; 164:918.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Danelich IM, Lose JM, Wright SS, et al. Practical management of postoperative atrial fibrillation after noncardiac surgery. J Am Coll Surg 2014; 219:831.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McAlister FA, Youngson E, Jacka M, et al. A comparison of four risk models for the prediction of cardiovascular complications in patients with a history of atrial fibrillation undergoing non-cardiac surgery. Anaesthesia 2020; 75:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mayet S, Gossop M, Lintzeris N, et al. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation? Drug Alcohol Rev 2011; 30:388.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pearson EC, Woosley RL. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system. Pharmacoepidemiol Drug Saf 2005; 14:747.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Charbit B, Albaladejo P, Funck-Brentano C, et al. Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology 2005; 102:1094.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Charbit B, Alvarez JC, Dasque E, et al. Droperidol and ondansetron-induced QT interval prolongation: a clinical drug interaction study. Anesthesiology 2008; 109:206.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Devereaux PJ, Sessler DI. Cardiac Complications in Patients Undergoing Major Noncardiac Surgery. N Engl J Med 2015; 373:2258.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ruetzler K, Smilowitz NR, Berger JS, et al. Diagnosis and Management of Patients With Myocardial Injury After Noncardiac Surgery: A Scientific Statement From the American Heart Association. Circulation 2021; 144:e287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Hert SG, Lurati Buse GA. Cardiac Biomarkers for the Prediction and Detection of Adverse Cardiac Events After Noncardiac Surgery: A Narrative Review. Anesth Analg 2020; 131:187.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ruetzler K, Khanna AK, Sessler DI. Myocardial Injury After Noncardiac Surgery: Preoperative, Intraoperative, and Postoperative Aspects, Implications, and Directions. Anesth Analg 2020; 131:173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           London MJ, Hollenberg M, Wong MG, et al. Intraoperative myocardial ischemia: localization by continuous 12-lead electrocardiography. Anesthesiology 1988; 69:232.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Botto F, Alonso-Coello P, Chan MT, et al. Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology 2014; 120:564.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nagele P. Perioperative Myocardial Injury and Infarction: Top-20 List of What We Know and What We Don't. Anesth Analg 2020; 131:170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liem VGB, Hoeks SE, Mol KHJM, et al. Postoperative Hypotension after Noncardiac Surgery and the Association with Myocardial Injury. Anesthesiology 2020; 133:510.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sigmund AE, Fang Y, Chin M, et al. Postoperative Tachycardia: Clinically Meaningful or Benign Consequence of Orthopedic Surgery? Mayo Clin Proc 2017; 92:98.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Turan A, Leung S, Bajracharya GR, et al. Acute Postoperative Pain Is Associated With Myocardial Injury After Noncardiac Surgery. Anesth Analg 2020; 131:822.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 94349 Version 29.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1554116" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Complications occurring in the postanesthesia care unit: a survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8638830" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Cardiovascular events in the postanesthesia care unit: contribution of risk factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12392453" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Recovery room incidents: a review of 419 reports from the Anaesthetic Incident Monitoring Study (AIMS).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29337744" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Defining the Intrinsic Cardiac Risks of Operations to Improve Preoperative Cardiac Risk Assessments.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17667564" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22133448" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Safe surgery: how accurate are we at predicting intra-operative blood loss?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6650916" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Pulmonary edema following naloxone administration in a patient without heart disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29787410" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : The Effect of Dexmedetomidine on Propofol Requirements During Anesthesia Administered by Bispectral Index-Guided Closed-Loop Anesthesia Delivery System: A Randomized Controlled Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28854543" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Dexmedetomidine pharmacodynamics in healthy volunteers: 2. Haemodynamic profile.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12707156" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Differing incidences of relevant hypotension with combined spinal-epidural anesthesia and spinal anesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29133356" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25278775" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Optimal perioperative management of arterial blood pressure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21493093" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Hemodynamic control and clinical outcomes in the perioperative setting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15931336" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Undiagnosed pheochromocytoma: the anesthesiologist nightmare.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22221507" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Case 1--2012. A perfect storm: fatality resulting from metoclopramide unmasking a pheochromocytoma and its management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9444533" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Pheochromocytomas and anesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28731975" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : The Consensus Bundle on Hypertension in Pregnancy and the Anesthesiologist: Doing All the Right Things for All the Patients All of the Time.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28389189" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : To Stop Or Not? Withholding Anti-hypertensive Therapy Before Surgery Is Not Safe.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7631944" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Multivariate determinants of early postoperative oxygen consumption in elderly patients. Effects of shivering, body temperature, and gender.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8122750" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Severe postoperative shivering and hypoglycaemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11818783" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Perioperative shivering: physiology and pharmacology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9087467" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. A randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19352147" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Postoperative urinary retention: anesthetic and perioperative considerations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20659610" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Prevalence and predictive factors of urinary retention assessed by ultrasound in the immediate post-anesthetic period.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24815969" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Perioperative analgesia and challenges in the drug-addicted and drug-dependent patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26927748" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Preoperative Evaluation of the Patient with Substance Use Disorder and Perioperative Considerations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16534357" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Anesthetic management of the illicit-substance-using patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11484693" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Cardiovascular complications of cocaine use.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25915204" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Update on perioperative care of the cardiac patient for noncardiac surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23194493" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25127508" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Practical management of postoperative atrial fibrillation after noncardiac surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31282570" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : A comparison of four risk models for the prediction of cardiovascular complications in patients with a history of atrial fibrillation undergoing non-cardiac surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21355918" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15918160" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15915019" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18648229" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Droperidol and ondansetron-induced QT interval prolongation: a clinical drug interaction study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26630144" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Cardiac Complications in Patients Undergoing Major Noncardiac Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34601955" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Diagnosis and Management of Patients With Myocardial Injury After Noncardiac Surgery: A Scientific Statement From the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32102011" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Cardiac Biomarkers for the Prediction and Detection of Adverse Cardiac Events After Noncardiac Surgery: A Narrative Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31880630" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Myocardial Injury After Noncardiac Surgery: Preoperative, Intraoperative, and Postoperative Aspects, Implications, and Directions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3407971" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Intraoperative myocardial ischemia: localization by continuous 12-lead electrocardiography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24534856" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32541590" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Perioperative Myocardial Injury and Infarction: Top-20 List of What We Know and What We Don't.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32487822" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Postoperative Hypotension after Noncardiac Surgery and the Association with Myocardial Injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27890407" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Postoperative Tachycardia: Clinically Meaningful or Benign Consequence of Orthopedic Surgery?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32665475" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Acute Postoperative Pain Is Associated With Myocardial Injury After Noncardiac Surgery.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
